SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing heavy downward pressure as investors aggressively penalize the company's decision to hike its annual capital expenditure guidance, despite delivering a strong earnings and revenue beat. The community remains deeply divided, with some investors viewing the pullbacks as a buying opportunity given Meta's sustained double-digit growth, while others express growing frustration over the ballooning AI spending and ongoing legal headwinds.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is surging to new highs as investors react to reports of a prolonged naval blockade on Iran and heightening supply fears in the Strait of Hormuz. The community is intensely debating whether this rally is an unstoppable energy-driven shock or a speculative bubble poised for a sharp reversal if diplomatic negotiations yield a breakthrough.

Addentax Group Corp. is a holding company, along with its subsidiaries, engages in the textile and garments industry. It operates through the following segments: Garment Manufacturing, Logistics Services, and Property Management and Subleasing. The Garments Manufacturing segment focuses on manufacturing and distribution of garments. The Logistics Services segment includes delivery and courier services covering some provinces in China. The Property Management and Subleasing segment offers services for wholesalers and retailers. The company was founded on October 28, 2014 and is headquartered in Shenzhen, China.

Addentax Group Corp

Addentax Group Corp. is trending as retail traders monitor its volatile, low-float structure and recent fintech acquisition news, frequently comparing it to other recent China-based short-squeeze runners. The community is actively debating the stock's potential for rapid price swings fueled by its tiny float and speculative interest in upcoming corporate developments.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing high volatility and increased trading volume as market participants speculate on the company's potential role in the growing AI data center power demand. Community discussions are split between optimistic bulls anticipating large-scale contracts and sector sympathy plays, and skeptical investors expressing frustration over historical dilution and limited operational updates.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing renewed investor interest driven by a significant contract win to supply specialized MRAM process technology to the U.S. defense sector. Community sentiment highlights the company's unique position as a domestic supplier of radiation-hardened memory, fueling long-term discussions about its role in AI edge computing, aerospace, and critical infrastructure.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors digest a massive earnings beat fueled by accelerating cloud growth and record search revenue, despite ongoing community debate over the sustainability of high AI capital expenditures. The stock remains a core focus for traders monitoring the hyperscaler arms race and the broader impact of AI infrastructure spending on long-term shareholder value.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors aggressively position for its upcoming quarterly earnings, with the community closely tracking whether its significant capital expenditure in AI and cloud infrastructure will translate into immediate revenue growth. Sentiment remains highly bullish ahead of the report, as market participants analyze the company's competitive standing in search and cloud against other tech giants.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is at the center of intense market focus as investors await earnings, with the community closely tracking AWS growth and the company's massive capital expenditure for AI infrastructure. The stock has seen significant call-side conviction and bullish sentiment, as participants look for a clear signal on how these aggressive investments are translating into cloud monetization and long-term profitability.

Rising Dragon Acquisition Corp. is a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on March 8, 2024 and is headquartered in Taiyuan, China.

Rising Dragon Acquisition Corp.

Rising Dragon Acquisition Corp. is drawing significant attention from retail traders who are focused on its exceptionally low float and potential for rapid price volatility. Community members are actively analyzing SEC filings, such as redemption rates and extension fees, while comparing the ticker's performance to other recent small-cap movers in the China-based sector.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is facing heightened volatility and community debate as investors react to a recent analyst upgrade and buyout speculation spurred by sector peers. While some long-term shareholders remain focused on the company's potential to scale BetterHelp and improve margins, others are actively criticizing management's leadership and the stock's significant decline, keeping the discussion centered on a potential acquisition target.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Polaryx Therapeutics (NASDAQ:PLYX) Trading 4.9% Higher - Time to Buy?

Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 4.9% - Here's Why...

Polaryx Therapeutics (NASDAQ:PLYX) Stock Price Down 1.9%  - Time to Sell?

Polaryx Therapeutics (NASDAQ:PLYX) Trading Down 1.9% - Time to Sell...

<ul class="summary-bullets"><li>Polaryx Therapeutics went public via a direct listing on Feb. 2.</li><li>The biotech firm is developing treatments for lysosomal storage disorders (LSDs).</li><li>Stocktwits sentiment for PLYX shifted to ‘extremely bullish’ after the stock rally.</li></ul><p>Shares of Polaryx Therapeutics (PLYX), a newly listed clinical-stage biotech firm, surged 70% on Tuesday,&nbsp;its best session on record, spurring increased interest from retail traders on Stocktwits. The micro-cap stock surged 29% on Monday.</p><h2 class="st-heading-2"><strong>Biotech Stocks Drawing Interest</strong></h2><p>Polaryx is focused on rare neurodegenerative diseases and is currently testing its PLX-200 treatment aimed at treating lysosomal storage disorders (LSDs), genetic diseases where the body can’t break down certain molecules, causing harmful buildup inside cells.</p><p>Biotech names have been catching investors' eyes as they seek shelter from the market turbulence triggered by the US-Israel conflict with Iran. Drug stocks have emerged as a go-to safe haven amid all the geopolitical uncertainty this year: the&nbsp;<a href="https://stocktwits.com/symbol/XBI">SPDR S&amp;P Biotech ETF</a> (XBI) has gained over 4% this year while the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF Trust</a> (SPY) and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust Series 1</a> (QQQ) index funds (which track the benchmark U.S. indices) have shed about 1%.</p><p>Polaryx’s pipeline includes four drug candidates, namely, PLX-200, PLX-100, PLX-300, and PLX-400 for LSDs. The last three are still in the preclinical stage.</p><h2 class="st-heading-2"><strong>Recent Updates From PLYX</strong></h2><p>The recent uptrend in the stock was likely triggered as investors took note of the company’s research advances. The company&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.nasdaq.com/articles/polaryx-initiate-soteria-phase-2-basket-trial-1h2026-stock?utm_source=chatgpt.com">announced</a> on Feb. 17 that it was moving forward with its phase-2 trial evaluating PLX-200 in four lysosomal storage disorders (LSDs) after receiving a “safe-to-proceed” letter from the Food and Drug Administration in October.</p><p>Last week, Maxim initiated coverage on the PLYX with a ‘Buy’ rating and $10 price target, which implies a 66% upside to the stock’s last close. The firm said it views PLX-200 as a differentiated offering, given its oral formulation and potential to address a broad spectrum of LSDs by targeting shared disease pathways.</p><h2 class="st-heading-2"><strong>Retail’s View On PLYX</strong></h2><p>On Stocktwits, retail sentiment for PLYX shifted to ‘extremely bullish’ as of early Wednesday, from ‘bullish’ the prior day, amid ‘extremely high’ message volume. The watcher count for&nbsp;<a href="https://stocktwits.com/symbol/PLYX">PLYX</a> on the platform increased nearly 50% over the past 24 hours.</p><p>Several users&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.stocktwits.com/NorthernMonkey1/message/647157001">said</a> they would be watching the stock in the coming days.</p><p>“$PLYX development stage biotech that traders tend to position in ahead of pipeline progress updates. These setups usually need sustained volume to get momentum going,” one trader&nbsp;<a href="https://stocktwits.com/topstockalerts/message/647155307">said</a>, explaining the prevailing view.</p><p>About 25 million PLYX shares exchanged hands on Tuesday, about nine times the stock’s average trading volume, according to Stocktwits data.</p><h2 class="st-heading-2"><strong>Stock Widely Down Since Listing</strong></h2><p>Polaryx’s recent gains come&nbsp;as a relief, as the stock slid sharply after its direct listing on the Nasdaq on Feb. 2. Shares currently trade at about one-tenth of their opening price of $45.00 that day.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oracle-shuts-up-the-bears-as-ceo-touts-faster-cheaper-ai-wall-street-is-totally-buying-it/cZdANc5RIJT">Oracle Shuts Up The Bears As CEO Touts 'Faster, Cheaper' AI: Wall Street Is Totally Buying It</a></p>

Traders work on the floor of the New York Stock Exchange.

Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest?

Watcher count for PLYX on Stocktwits increased by nearly 50% in a single day.

PLYX Stock Rockets To Best Day Ever: Why Retail Traders Are Piling Into This Battered Biotech

Equity

Watcher count for PLYX on Stocktwits increased by nearly 50% in a single day.


Maxim Group Begins Coverage on Polaryx Therapeutics (NASDAQ:PLYX)

Maxim Group began coverage on Polaryx Therapeutics in a report on Friday. They set a "buy" rating and a $10.00 price objective on the stock...

Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 15.2% - Here's Why

Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 15.2% - Here's Why...

What's Going On With Polaryx Therapeutics Stock Wednesday?

Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.read more...

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans

Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.read more...

Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.

Polaryx Therapeutics Inc.

$GOOGL

$MSFT

$AMZN

$META

Which Mag 7 name makes the biggest move after earnings today?

PLYX
Polaryx Therapeutics Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest PLYX News

PLYXPolaryx Therapeutics Inc.